Lincoln Pharmaceuticals has informed that pursuant to the provisions of section 124 (6) of the Companies Act, 2013 and Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has enclosed the copies of notice published in the newspaper on May 15, 2023 as required under Rule 6 of IEPF Authority (Accounting, Audit, Transfer and Refund) Rules, 2016 and amendments thereof, inviting attention of concerned shareholders to lodge their claims in respect of unclaimed dividends for last seven consecutive years, failing which their equity shares would be transferred to IEPF Authority.
The above information is a part of company’s filings submitted to BSE.
